SCHEMBL1664969

SCHEMBL1664969

CCOC1CCN(c2ccc(Nc3ccc(Nc4ccc(NC(=O)c5cc[nH]c5)cc4F)cc3)cc2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.41
MEN1 O00255 4/20 0.41
MAPT P10636 7/20 0.40
HSD17B10 Q99714 3/20 0.40
ALOX15 P16050 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 4/20 0.40
NPC1 O15118 6/20 0.40
RAB9A P51151 6/20 0.40
SMN1; SMN2 Q16637 5/20 0.40
ALOX12 P18054 1/20 0.40
NR4A1 P22736 1/20 0.40
POLB P06746 4/20 0.39
LMNA P02545 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.39
MAPK1 P28482 1/20 0.39
TSHR P16473 2/20 0.38
TAAR1 Q96RJ0 1/20 0.38
LRRK2 Q5S007 1/20 0.37
EGFR P00533 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664971 0.97 KMT2A (0.44) KMT2AMEN1MAPTHSD17B10ALOX15
SCHEMBL1664879 0.87 NPC1 (0.41) KMT2AMEN1MAPTALOX15ALDH1A1
SCHEMBL1663777 0.84 NPC1 (0.45) KMT2AMEN1MAPTALOX15NPC1
SCHEMBL1664881 0.84 NPC1 (0.45) KMT2AMEN1MAPTALOX15NPC1
SCHEMBL1664099 0.84 NPC1 (0.41) KMT2AMEN1MAPTALOX15ALDH1A1
SCHEMBL21254702 0.84 MAPT (0.45) KMT2AMEN1MAPTHSD17B10ALOX15
SCHEMBL1665045 0.83 KMT2A (0.42) KMT2AMEN1MAPTHSD17B10ALOX15
SCHEMBL6126048 0.83 NPC1 (0.43) KMT2AMEN1MAPTHSD17B10ALOX15
SCHEMBL1665043 0.82 NPC1 (0.42) HSD17B10ALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL6126046 0.82 GPR6 (0.45) KMT2AMEN1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed